Related Experiment Video

Updated: Jun 4, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for

Nikos G Gavalas1, Alexandra Karadimou, Meletios A Dimopoulos

  • 1Department of Clinical Therapeutics, Medical School, University of Athens, Alexandra Hospital, 80 Vasilissis Sofias Avenue, 115 28 Athens, Greece.

Clinical & Developmental Immunology
|February 15, 2011
PubMed

Insights

Ovarian cancer often becomes resistant to chemotherapy. Research is exploring the immune system, including T cells and cytokines, to understand and improve antitumor responses against this disease.

Area of Science:

  • Immunology
  • Oncology
  • Gynecologic Oncology

Background:

  • Ovarian cancer is a leading cause of cancer death in women.
  • Chemotherapy resistance (paclitaxel, platinum agents) affects over 70% of cases.
  • The host immune response is a critical area of research for ovarian cancer.

Purpose of the Study:

  • To review recent advancements in understanding ovarian cancer immune response mechanisms.
  • To explore the prognostic significance of immune components in ovarian cancer.
  • To summarize clinical study experiences in harnessing the immune system for ovarian cancer treatment.

Main Methods:

  • Review of current literature on ovarian cancer immunology.
  • Analysis of studies investigating T cell populations (NK T cells, Tregs) and cytokines.
  • Examination of clinical trial data related to immunotherapies for ovarian cancer.

Main Results:

  • T cell populations and cytokines are linked to ovarian cancer prognosis and disease progression.
  • Understanding immune mechanisms is key to overcoming chemotherapy resistance.
  • Clinical studies show varying success in inducing antitumor responses via immune modulation.

Conclusions:

  • The immune system plays a significant role in ovarian cancer development and outcome.
  • Targeting immune responses offers potential for novel ovarian cancer therapies.
  • Further research is needed to effectively harness the immune system against ovarian cancer.

More Related Videos

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...